FOXP3 and allergic disease: Interestingly, transfer of constitutive Foxp3+ Treg to DEREG mice appeared sufficient to improve systemic symptoms of allergy and accelerate clinical recovery, suggesting that their suppressive efficacy is either T cell-receptor independent or involves T cell receptor activation by self or endogenous ligands.